BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 29316729)

  • 21. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.
    Azzolin L; Panciera T; Soligo S; Enzo E; Bicciato S; Dupont S; Bresolin S; Frasson C; Basso G; Guzzardo V; Fassina A; Cordenonsi M; Piccolo S
    Cell; 2014 Jul; 158(1):157-70. PubMed ID: 24976009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R-spondins can potentiate WNT signaling without LGRs.
    Lebensohn AM; Rohatgi R
    Elife; 2018 Feb; 7():. PubMed ID: 29405118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.
    Carmon KS; Gong X; Yi J; Thomas A; Liu Q
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1221-9. PubMed ID: 24639526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms.
    Bai Z; Wu Q; Zhang C; Chen J; Cao L
    J Gastrointest Oncol; 2021 Aug; 12(4):1601-1612. PubMed ID: 34532114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAZ exhibits phase separation properties and interacts with Smad7 and β-catenin to repress skeletal myogenesis.
    Tripathi S; Miyake T; Kelebeev J; McDermott JC
    J Cell Sci; 2022 Jan; 135(1):. PubMed ID: 34859820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis.
    Zhang J; Zhou Y; Tang PMK; Cheng ASL; Yu J; To KF; Kang W
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
    Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
    BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.
    Li P; Silvis MR; Honaker Y; Lien WH; Arron ST; Vasioukhin V
    Genes Dev; 2016 Apr; 30(7):798-811. PubMed ID: 27013234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis.
    Han Q; Lin X; Zhang X; Jiang G; Zhang Y; Miao Y; Rong X; Zheng X; Han Y; Han X; Wu J; Kremerskothen J; Wang E
    J Pathol; 2017 Aug; 242(4):435-447. PubMed ID: 28543074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation.
    Fallah S; Beaulieu JF
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling.
    Chen HZ; Liu QF; Li L; Wang WJ; Yao LM; Yang M; Liu B; Chen W; Zhan YY; Zhang MQ; Cai JC; Zheng ZH; Lin SC; Li BA; Wu Q
    Gut; 2012 May; 61(5):714-24. PubMed ID: 21873734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.
    Rosenbluh J; Nijhawan D; Cox AG; Li X; Neal JT; Schafer EJ; Zack TI; Wang X; Tsherniak A; Schinzel AC; Shao DD; Schumacher SE; Weir BA; Vazquez F; Cowley GS; Root DE; Mesirov JP; Beroukhim R; Kuo CJ; Goessling W; Hahn WC
    Cell; 2012 Dec; 151(7):1457-73. PubMed ID: 23245941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
    Kaneda A; Seike T; Danjo T; Nakajima T; Otsubo N; Yamaguchi D; Tsuji Y; Hamaguchi K; Yasunaga M; Nishiya Y; Suzuki M; Saito JI; Yatsunami R; Nakamura S; Sekido Y; Mori K
    Am J Cancer Res; 2020; 10(12):4399-4415. PubMed ID: 33415007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic and Nuclear TAZ Exert Distinct Functions in Regulating Primed Pluripotency.
    Zhou X; Chadarevian JP; Ruiz B; Ying QL
    Stem Cell Reports; 2017 Sep; 9(3):732-741. PubMed ID: 28844657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription.
    Li Q; Sun Y; Jarugumilli GK; Liu S; Dang K; Cotton JL; Xiol J; Chan PY; DeRan M; Ma L; Li R; Zhu LJ; Li JH; Leiter AB; Ip YT; Camargo FD; Luo X; Johnson RL; Wu X; Mao J
    Cell Stem Cell; 2020 May; 26(5):675-692.e8. PubMed ID: 32259481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.
    García P; Rosa L; Vargas S; Weber H; Espinoza JA; Suárez F; Romero-Calvo I; Elgueta N; Rivera V; Nervi B; Obreque J; Leal P; Viñuela E; Aguayo G; Muñiz S; Sagredo A; Roa JC; Bizama C
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32218280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-talk between Hippo and Wnt signalling pathways in intestinal crypts: Insights from an agent-based model.
    Ward D; Montes Olivas S; Fletcher A; Homer M; Marucci L
    Comput Struct Biotechnol J; 2020; 18():230-240. PubMed ID: 33489001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury.
    Deng F; Wu Z; Zou F; Wang S; Wang X
    Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.